Data presented at virtual European Academy of Dermatology and Venereology congress
Category: Uncategorized
Partnership aims to advance disease severity testing programme for COVID-19
Gilead and Galapagos’ application for oral JAK1 inhibitor validated by agency
Updated Date: Mon, 26 Oct 2020 00:00:00 EDT
Updated Date: Mon, 26 Oct 2020 00:00:00 EDT
Updated Date: Mon, 26 Oct 2020 00:00:00 EDT
Updated Date: Mon, 26 Oct 2020 00:00:00 EDT
Updated Date: Mon, 26 Oct 2020 00:00:00 EDT
Research on anti-cancer drug response in patient-derived artificial organoids and transcriptome learning of genes associated with anti-cancer target […]
Researchers at the University of Liverpool have identified a unique method of identifying the early signs of a […]